 |
Speaking of Women's HealthAuthor: SWH
The Speaking of Women's Health Podcast is excited to bring you credible women's health information from host and Executive Director, Dr. Holly L. Thacker. Dr. Thacker will interview guest clinicians discussing relevant women's health topics and the latest news and tips.Please consider supporting Speaking of Women's Health with a monetary donation to help us continue to provide free women's health content. Thank you! Language: en-us Genres: Fitness, Health & Fitness, Nutrition Contact email: Get it Feed URL: Get it iTunes ID: Get it |
Listen Now...
Non-Hormonal Menopause Relief
Episode 11
Wednesday, 25 March, 2026
Send us Fan MailHot flashes that hijack your day and wreck your sleep are more than a nuisance—they’re a brain‑level problem with real solutions. Speaking of Women's Health Podcast host Dr. Holly Thacker sits down with Dr. Nayoung Sung from Cleveland Clinic’s Center for Specialized Women’s Health to unpack a new non‑hormonal therapy, Lynkuet® (elinzanetant).For listeners weighing options, Dr. Sung and Dr. Thacker lay out who benefits most from non‑hormonal care—those with clotting risks, estrogen‑sensitive cancers, or simple preference to avoid hormones—and where low‑dose paroxetine, venlafaxine, gabapentin, and oxybutynin still fit when personalized thoughtfully.Relief should also respect the rest of your health. We dive into sexual wellness with local vaginal estrogen or DHEA for tissue comfort, and we zoom out to the metabolic picture: abdominal weight gain, high triglycerides, insulin resistance, and inflammation that magnify heat, pain, and brain fog. Dr. Sung shares early findings on omega‑3 and omega‑6 balance, ferritin, zinc, and CRP—and how small diet shifts and targeted testing can support clearer thinking and steadier energy alongside symptom control.If you’re searching for safe, swift, and truly personalized menopause care, this conversation delivers. Subscribe, leave a review, and share this episode with someone who deserves cooler nights and brighter days—what question do you want us to tackle next?Support the show
